BPIA submitted comments to the National Organic Standards Board to help rectify the USDA organic regulations’ references to the outdated EPA inert ingredient Lists 3 and 4 and improve the policies and procedures for establishing allowable pesticide inert ingredients for use in organic crop and livestock production.

BPIA and other stakeholders submitted a proposal to the CFIA to permit registrants to change suppliers of certain ingredients without submitting an Ingredient Source Change Inquiry.

BPIA filed comments regarding an ANPR concerning the EPA’s approach to regulation of seeds treated with a pesticide registered under FIFRA.

Please join us for the BPIA 2024 Annual Meeting in Washington, DC on March 26-27, 2024!

BPIA submitted comments to the National Organic Standards Board regarding allowable biological pesticide inert ingredients for use in organic crop production.

BPIA filed comments regarding Pesticide Registration Improvement Act Bilingual Labeling Requirements.

BPIA submitted comments regarding policy for addressing missing/incomplete data during the scientific evaluation process

BPIA filed comments regarding EPA’s Draft Guidance Regarding Endangered Species Act Consideration.

BPIA submits comments regarding Draft Guidance on Field Trial Requirements for Efficacy and Phytotoxicity.

BPIA submits comments regarding proposed changes to the California Pesticide Registration Branch workload assignments.

BPIA applauds the bipartisan introduction of the Plant Biostimulant Act of 2023 in the Senate and the U.S. House of Representatives (H.R. 1472). BPIA thanks Senators Mike Braun (R-IN) and Alex Padilla (D-CA) as well as Congressmen Jimmy Panetta (D-CA) and Jim Baird (R-IN) for sponsoring the bill.

BPIA and other industry stakeholders suggested the PMRA consider reviewing and modernizing regulations for dual property products containing crop protection and crop health improvement properties to enable registration of these products under single label.

BPIA hosted a virtual listening session regarding biostimulants to support the National Biotechnology and Biomanufacturing Initiative.

BPIA provided input to the White House Office of Science and Technology Policy regarding the Coordinated Framework to accelerate biotechnology innovation and grow America’s bioeconomy.

BPIA provided a response to the PMRA’s request for comments regarding PRO2022-01 Pre-Consultation – Proposed Regulatory Amendments to the Pest Control Products Regulations